Eccentric Motor Control After SCI
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02821845 |
Recruitment Status :
Completed
First Posted : July 4, 2016
Last Update Posted : March 22, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Spinal Cord Injury | Behavioral: Untrained and Trained SCI Hip or Knee |
Study Type : | Observational |
Actual Enrollment : | 49 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | Eccentric Motor Control Training to Improve Human Spinal Cord Injury: Observation of Hip and Knee Function |
Study Start Date : | June 2015 |
Actual Primary Completion Date : | October 2019 |
Actual Study Completion Date : | October 2019 |

Group/Cohort | Intervention/treatment |
---|---|
Control
Individuals with no spinal cord injury or other neurological deficits.
|
|
Untrained and Trained SCI Hip and Knee
Individuals with spinal cord injury who have been discharged from a locomotor training program at least 6 months prior to enrollment in this study. Untrained individuals will complete 3 baseline measures and then complete eccentric training which will focus on rehabilitation of the hip joint or knee joint.
|
Behavioral: Untrained and Trained SCI Hip or Knee
Individuals with SCI will perform downhill walking training 3 times a week for 12 wks with a 4 wk follow-up period. This intervention will be delivered by trained therapists. In order to focus on rehabilitation of hip control or knee control, members of this group will be trained at slow to moderate gait speeds,
Other Name: DH Hip or Knee |
- Change from baseline in time to complete 6 minutes of level walking (i.e., the 6 minute walk test) [ Time Frame: baseline, 12 weeks ]
- Change from baseline in time to complete 10 meters of level walking (i.e., the 10 meter walk test) [ Time Frame: baseline, 12 weeks ]
- Change from baseline in peak magnitude of frontal hip loading response as measured by the peak magnitude of frontal hip power absorption during the weight acceptance phase of walking [ Time Frame: baseline, 12 weeks ]
- Change from baseline in Neuromuscular Recovery Scale score [ Time Frame: baseline, 12 weeks ]
- Change from baseline in balance function as measured by the Berg Balance Scale score [ Time Frame: baseline, 12 weeks ]
- Change from Baseline in SCI specific Quality of Life score [ Time Frame: baseline, 12 weeks ]
- Change from second baseline in time to complete 6 minutes of level walking (i.e., the 6 minute walk test) [ Time Frame: 12 weeks, 16 weeks ]
- Change from second baseline in time to complete 10 meters of level walking (i.e., the 10 meter walk test) [ Time Frame: 12 weeks, 16 weeks ]
- Change from second baseline in peak magnitude of frontal hip loading response as measured by the peak magnitude of frontal hip power absorption during the weight acceptance phase of walking [ Time Frame: 12 weeks, 16 weeks ]
- Change from second baseline in quadriceps eccentric contraction capacity as measured by difference in maximum voluntary eccentric knee flexion contraction before and after eccentric exercise targeting the contralateral quadriceps [ Time Frame: 12 weeks, 16 weeks ]
- Change from second baseline in Neuromuscular Recovery Scale score [ Time Frame: 12 weeks, 16 weeks ]
- Change from second baseline in balance function as measured by Berg Balance Scale score [ Time Frame: 12 weeks, 16 weeks ]
- Change from second baseline in SCI specific Quality of Life score [ Time Frame: 12 weeks, 16 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 90 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Individuals with SCI:
Inclusion Criteria:
- medically approved
- discharged from outpatient rehabilitation for 6 months
- incomplete SCI based on ASIA impairment score (AIS C or D) at neurologic level C1-T10
- ability to take some steps overground and on the treadmill
- 18-90 years old.
- ability to speak English. Note: the quality of life measures have not been validated yet in non-English speaking populations.
Exclusion Criteria:
- evidence of lower motor neuron injury in the legs
- use of botox in the past 3 months
- pre-existing or confounding neurologic conditions (i.e. brain injury, stroke, HIV)
- acute deep vein thrombosis
- skin wounds in regions where harness or hands provide support
- pregnancy. Note: Persons who are pregnant will not be enrolled as exercise tolerance is unknown in these women with SCI.
- cognitive conditions that preclude providing informed consent
- ventilator-dependence as study results will be confounded by mobility limitations imposed by equipment
- persistent orthostatic hypotension (drop of BP >30mmHg in treadmill and harness equipment)
- hospitalization for myocardial infarction, cardiac surgery or congestive heart failure exacerbation within 3 months of enrollment in study
- participation in any other concurrent exercise programs.
Note: Use of anti-spasticity and other medications (dose, frequency) will be monitored throughout training and used as a confounding variable in the analyses.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02821845
United States, Ohio | |
The Ohio State University | |
Columbus, Ohio, United States, 43210 |
Principal Investigator: | D. Michele M Basso | Ohio State University |
Responsible Party: | Michele Basso, Professor, Ohio State University |
ClinicalTrials.gov Identifier: | NCT02821845 |
Other Study ID Numbers: |
2014H0386-2 |
First Posted: | July 4, 2016 Key Record Dates |
Last Update Posted: | March 22, 2021 |
Last Verified: | March 2021 |
Spinal Cord Injuries Spinal Cord Diseases Central Nervous System Diseases |
Nervous System Diseases Trauma, Nervous System Wounds and Injuries |